Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with $1.2 billion under management. Pontifax portfolio comprises over 100 companies that develop breakthrough solutions to substantial unmet needs with cutting-edge life sciences technologies at all development stages.
Wille AG is a Family Office based in Switzerland. Wille AG is an active private equity investor in Life Science and Software venture companies as well as in Buy-Out companies. Wille’s portfolio encompasses more than 40 companies across Europe, Israel and the US.
Mori Arkin founded Arkin Holdings in 2009, with the vision of creating a professional and financial platform. The aim of Arkin Holdings is to empower pioneering developments in healthcare, focusing on pharmaceuticals, biotechnology medical devices and digital health technologies. Arkin Holdings synergistic healthcare investments are focused on creating innovations that benefit humanity and enhance medical care.
GIBF is an investment fund that invests through a unique model that provides Israeli, European and American companies with tailor-made pathways to enter the Chinese market. As opposed to the common distribution or local partnership models, GIBF help establish and invests into Chinese JVs in partnership with international technology companies, in which the foreign company (parent company) remains as the majority shareholder responsible for the management, operations and long-term vision of the JV. This model therefore allows the IP and the value created in China to remain in the hands of the parent company.